本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
盘后5.320.00000.00%16:16 EDT
成交量:5,757.08万
成交额:3.24亿
市值:23.10亿
市盈率:-2.95
高:6.20
开:6.04
低:5.30
收:5.91
52周最高:12.36
52周最低:3.79
股本:4.34亿
流通股本:4.15亿
量比:1.09
换手率:13.87%
股息:- -
股息率:- -
每股收益(TTM):-1.8042
每股收益(LYR):-1.6909
净资产收益率:-86.34%
总资产收益率:-39.08%
市净率:2.51
市盈率(LYR):-3.15

数据加载中...

2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities